Tim Leest (born 1982) is Chair of the Committee for Orphan Medicinal Products (COMP) at the European Medicines Agency and Senior Clinical Assessor at the Belgian Federal Agency for Medicines and Health Products (FAMHP), a role he has held since 2008. He obtained master’s degrees in Biology and Bioinformatics from the Catholic University of Leuven (KUL). From 2007 to 2024, he served as the Belgian delegate to the COMP and was elected Chair in 2024. He has also been a member of the Management Board of the Fund Rare Diseases of the King Baudouin Foundation and contributes to several European rare disease initiatives.
